Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review ; volume:19 ; number:1 ; day:30 ; month:6 ; year:2021 ; pages:1-8 ; date:12.2021
Pediatric rheumatology ; 19, Heft 1 (30.6.2021), 1-8, 12.2021
- Creator
-
Yeung, Tsz-Wing
Cheong, Kai-Ning
Lau, Yu-Lung
Tse, Kei-Chiu Niko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-021-00595-1
- URN
-
urn:nbn:de:101:1-2021101221423575572679
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yeung, Tsz-Wing
- Cheong, Kai-Ning
- Lau, Yu-Lung
- Tse, Kei-Chiu Niko
- SpringerLink (Online service)
Other Objects (12)
Juvenile Dermatomyositis
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
Juvenile Dermatomyositis – Kombinationstherapie überlegen
Juvenile Dermatomyositis—Clinical Phenotypes
Dyslipidemia in Juvenile Dermatomyositis
COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Dyslipidemia in active juvenile dermatomyositis patients
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Juvenile Dermatomyositis
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
Juvenile Dermatomyositis – Kombinationstherapie überlegen
Juvenile Dermatomyositis—Clinical Phenotypes
Dyslipidemia in Juvenile Dermatomyositis
COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Dyslipidemia in active juvenile dermatomyositis patients
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Juvenile Dermatomyositis
Clinical nomogram assisting in discrimination of juvenile dermatomyositis-associated interstitial lung disease
Juvenile Dermatomyositis – Kombinationstherapie überlegen
Juvenile Dermatomyositis—Clinical Phenotypes
Dyslipidemia in Juvenile Dermatomyositis
COVID-19 or clinical amyopathic dermatomyositis associated rapidly progressive interstitial lung disease? A case report
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Acute lyme infection presenting with amyopathic dermatomyositis and rapidly fatal interstitial pulmonary fibrosis: a case report
Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis
Dyslipidemia in active juvenile dermatomyositis patients